OTC Markets EXMKT - Delayed Quote USD

Matricelf Ltd (MTRLF)

1.9000
0.0000
(0.00%)
At close: May 7 at 4:00:00 PM EDT
Loading Chart for MTRLF
  • Previous Close 0.0000
  • Open 1.9000
  • Bid --
  • Ask --
  • Day's Range 1.9000 - 1.9000
  • 52 Week Range 1.9000 - 1.9000
  • Volume 47,997
  • Avg. Volume 0
  • Market Cap (intraday) 30.7M
  • Beta (5Y Monthly) 0.52
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Matricelf Ltd, a biotechnology company, develops a platform for autologous tissue engineering for various medical conditions. The company's regenerative medicine platform intends to cure a range of medical conditions, including spinal cord injuries, age-related macular degeneration, Parkinson's disease, and myocardial infarction, as well as for 3D bioprinting. Matricelf Ltd was incorporated in 2019 and is based in Ness Ziona, Israel.

matricelf.com

12

Full Time Employees

December 31

Fiscal Year Ends

Recent News: MTRLF

View More

Performance Overview: MTRLF

Trailing total returns as of 5/18/2025, which may include dividends or other distributions. Benchmark is TA-125 (^TA125.TA) .

YTD Return

MTRLF
0.00%
TA-125 (^TA125.TA)
11.50%

1-Year Return

MTRLF
0.00%
TA-125 (^TA125.TA)
35.50%

3-Year Return

MTRLF
40.99%
TA-125 (^TA125.TA)
35.93%

5-Year Return

MTRLF
40.99%
TA-125 (^TA125.TA)
92.89%

Compare To: MTRLF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: MTRLF

View More

Valuation Measures

Annual
As of 5/16/2025
  • Market Cap

    14.02M

  • Enterprise Value

    14.02M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -41.48%

  • Return on Equity (ttm)

    -74.25%

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -16.11M

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -5.9M

Research Analysis: MTRLF

View More

Company Insights: MTRLF

Research Reports: MTRLF

View More